Junaidi Khotib

Junaidi Khotib., S.Si., Apt., M.Kes., Ph.D conducted his scientific research related to molecular study and medicine response when taken into body. Along with his team, he developed research concerning drug based on its compound’s activity structure which interacting with its target. This study is fundamental in development of medicine and procedure of its use. Development of this research enabled to find specific and selective medicines. Medicine only bonds with one target which activated one signaling pathway and giving one effect. Hence, such medicine has only main effect not side effect. One of Junaidi’s research, for instance: how to obtain therapy strategy on diabetes mellitus. Together with his team, he inhibited signaling pathway on development of diabetes mellitus from outside compounds. Junaidi intensively developed metal compound. The aim of that study was when barrier emerged, medicine activity would be optimal and tolerance in medicine use would not occur.

It was because diabetes mellitus medicine would be taken for long term. Furthermore, Junaidi also developed medicines for nerves aiming at inhibiting Alzheimer disease. By understanding the process of Alzheimer, its molecular process could be learned, then retardation could be executed. Once the activity is inhibited, development of the disease could be suppressed. Thus, Alzheimer would not occur. Besides research, Junaidi also wrote national and international publications, for instance: “Pharmaceutical interaction between cytostatic drugs and NaCl 0.9% and dextrose 5% infusion”, Asian Journal of Pharmaceutical and Clinical Research in 2014; and “The influence of sodium orthovanadate on p85 and gsk-3 expressions to the blood glucose regulation of type 2 diabetic mice (mus musculus) model”, International Journal of Pharmacy and Pharmaceutical Sciences in 2015. Junaidi received various awards for his dedication and research, such as: “High Achievement Lecturer (1st rank) at Airlangga University”; and “Finalist of High Achievement Lecturer” in 2009. (*)

AREAS OF EXPERTISE


CLINICAL PHARMACY, MOLECULAR PHARMACOLOGY, BIOEQUIVALENCE AND BIOSIMILARITY

Place and Date of Birth :

Jombang 22 October 1970

Email :

warek4@unair.ac.id

Phone :

+62-31 591 5552 | +6231 593 9934

Educational Background :
  1. Educational Background: Undergraduate program, Universitas Airlangga
  2. Master program, Universitas Airlangga
  3. Doctoral program, Hoshi University
Teaching Experience:
  1. Basic Biology Molecular
  2. Biology Molecular
  3. Pharmacology
  4. Pharmacogenomics
  5. Modern Biopharmaceutics
  6. Pharmacometrics Animal
  7. Modeling Multi-components Bioactivity
Research Areas:
  1. Molecular Pharmacology
  2. Bioequivalence and Biosimilarity

Book :

  1. Sintesis Organik (Indonesian translation of Organic Synthesis by Willis & Wills), page 92, Airlangga University Press (2004)

Leave a comment

Your email address will not be published. Required fields are marked *